tradingkey.logo

Telomir Pharmaceuticals Inc <TELO.OQ> expected to post a loss of 8 cents a share - Earnings Preview

ReutersAug 8, 2025 8:52 PM
  • Telomir Pharmaceuticals Inc TELO.OQ TELO.O is expected to report resultson August 11 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Telomir Pharmaceuticals Inc is for a loss of 8 cents per share.

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Telomir Pharmaceuticals Inc is $15.50, about 89.2% above its last closing price of $1.67

This summary was machine generated August 8 at 20:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI